Pieter E. Postmus mainly investigates Internal medicine, Lung cancer, Surgery, Cardiology and Pulmonary hypertension. His Internal medicine research incorporates elements of Gastroenterology and Oncology. His Oncology research is multidisciplinary, relying on both Carcinoma, Metastasis and Cohort.
His Lung cancer study combines topics in areas such as Clinical trial, Chemotherapy, Nuclear medicine, Thoracotomy and Stage. Pieter E. Postmus has researched Surgery in several fields, including Respiratory disease and Prophylactic cranial irradiation. The Cardiology study combines topics in areas such as Anesthesia, Magnetic resonance imaging and Blood pressure.
His primary areas of investigation include Internal medicine, Lung cancer, Surgery, Oncology and Respiratory disease. Pieter E. Postmus has included themes like Gastroenterology and Cardiology in his Internal medicine study. His Cardiology study combines topics from a wide range of disciplines, such as COPD and Blood pressure, Diastole.
Pieter E. Postmus combines subjects such as Stage, Cancer, Carcinoma and Radiology with his study of Lung cancer. His Oncology study integrates concerns from other disciplines, such as Etoposide, Toxicity and Docetaxel. His study in Pathology is interdisciplinary in nature, drawing from both Cancer research and Birt–Hogg–Dubé syndrome.
Internal medicine, Lung cancer, Oncology, Birt–Hogg–Dubé syndrome and Pneumothorax are his primary areas of study. Internal medicine is frequently linked to Gastroenterology in his study. The various areas that Pieter E. Postmus examines in his Lung cancer study include Stage, Cancer, Primary tumor and Lung.
The concepts of his Oncology study are interwoven with issues in Nab-paclitaxel and Durvalumab. Pneumothorax is a subfield of Surgery that Pieter E. Postmus tackles. His Surgery research focuses on Incidence and how it connects with Cohort.
His primary scientific interests are in Internal medicine, Lung cancer, Oncology, Surgery and Pneumothorax. His work on Chemotherapy, Autopsy and Myocardial infarction as part of general Internal medicine research is frequently linked to Power output, thereby connecting diverse disciplines of science. His Lung cancer research integrates issues from Stage, Cancer, Sputum and Radiology.
His Oncology research is multidisciplinary, incorporating elements of Nivolumab, Disease and Targeted therapy. His study focuses on the intersection of Surgery and fields such as Incidence with connections in the field of Cohort. His biological study spans a wide range of topics, including Emergency medicine and Medical emergency.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.
Peter Goldstraw;John Crowley;Kari Chansky;Dorothy J. Giroux.
Journal of Thoracic Oncology (2007)
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
Berend J Slotman;Corinne Faivre-Finn;Gijs Kramer;Elaine M Rankin.
The New England Journal of Medicine (2007)
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.
Harm van Tinteren;Otto S Hoekstra;Egbert F Smit;Jan Ham van den Bergh.
The Lancet (2002)
Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.
Serge A van Wolferen;Johannes T Marcus;Anco Boonstra;Koen M J Marques.
European Heart Journal (2007)
The international association for the study of lung cancer lung cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer
Frances A. Shepherd;John J. Crowley;Paul Van Houtte;Pieter E. Postmus.
Journal of Thoracic Oncology (2007)
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.
Andrea Ardizzoni;Heine Hansen;Per Dombernowsky;Teresa Gamucci.
Journal of Clinical Oncology (1997)
Prognostic factors in patients with pleural mesothelioma : The European Organization for Research and Treatment of Cancer Experience
D Curran;T Sahmoud;P Therasse;J van Meerbeeck.
Journal of Clinical Oncology (1998)
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.
Eric Vallières;Frances A. Shepherd;John J. Crowley;Paul Van Houtte.
Journal of Thoracic Oncology (2009)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan;Rachel Rosenthal;Crispin T. Hiley;Crispin T. Hiley;Andrew J. Rowan.
Cell (2017)
Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer
Klaas Kok;Jan Osinga;Ben Carritt;Mary B. Davis.
Nature (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
VU University Medical Center
VU University Medical Center
Vrije Universiteit Amsterdam
University of Amsterdam
Vrije Universiteit Amsterdam
Autonomous University of Madrid
National Institutes of Health
Washington University in St. Louis
Vrije Universiteit Amsterdam
VU University Medical Center
Georgia Institute of Technology
George Washington University
Southeast University
Technical University of Denmark
University of Tsukuba
University of Warwick
University of Tennessee at Knoxville
University of British Columbia
Brown University
Norwich Research Park
University of Southampton
University of Queensland
Feinstein Institute for Medical Research
Harvard University
University of Pittsburgh
Fermilab